Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.

Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE.

J Biol Chem. 2007 Mar 16;282(11):8110-22. Epub 2007 Jan 16.

2.

Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.

Kapitulnik J, Maines MD.

Trends Pharmacol Sci. 2009 Mar;30(3):129-37. doi: 10.1016/j.tips.2008.12.003. Epub 2009 Feb 11. Review.

PMID:
19217170
3.

The sevenfold way of PKC regulation.

Liu WS, Heckman CA.

Cell Signal. 1998 Sep;10(8):529-42. Review.

PMID:
9794251
4.

How is protein kinase C activated in CNS.

Huang KP, Huang FL.

Neurochem Int. 1993 May;22(5):417-33. Review.

PMID:
8485448
5.

Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways.

Maines MD.

Antioxid Redox Signal. 2007 Dec;9(12):2187-95. Review.

PMID:
17919068
6.

Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Breitkreutz D, Braiman-Wiksman L, Daum N, Denning MF, Tennenbaum T.

J Cancer Res Clin Oncol. 2007 Nov;133(11):793-808. Epub 2007 Jul 28. Review.

PMID:
17661083
7.

Involvement of B-50 (GAP-43) phosphorylation in the modulation of transmitter release by protein kinase C.

Iannazzo L.

Clin Exp Pharmacol Physiol. 2001 Nov;28(11):901-4. Review.

PMID:
11703393
8.

Protein kinase C and the cytoskeleton.

Keenan C, Kelleher D.

Cell Signal. 1998 Apr;10(4):225-32. Review.

PMID:
9617479
9.

Identification of myristoylated alanine-rich C kinase substrate (MARCKS) in astrocytes.

Vitkovic L, Aloyo VJ, Maeda S, Benzil DL, Bressler JP, Hilt DC.

Front Biosci. 2005 Jan 1;10:160-5. Print 2005 Jan 1. Review.

PMID:
15574358
10.

The role of intracellular proteinases in human neutrophil activation.

Pontremoli S, Melloni E.

Revis Biol Celular. 1989;20:161-77. Review.

PMID:
2561540
11.

Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity.

Irie K, Nakahara A, Nakagawa Y, Ohigashi H, Shindo M, Fukuda H, Konishi H, Kikkawa U, Kashiwagi K, Saito N.

Pharmacol Ther. 2002 Feb-Mar;93(2-3):271-81. Review.

PMID:
12191619
12.
13.

Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation.

Parker PJ, Bosca L, Dekker L, Goode NT, Hajibagheri N, Hansra G.

Biochem Soc Trans. 1995 Feb;23(1):153-5. Review. No abstract available.

PMID:
7758717
14.

Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies.

Sobhia ME, Grewal BK, Bhat J, Rohit S, Punia V.

Expert Opin Ther Targets. 2012 Mar;16(3):325-44. doi: 10.1517/14728222.2012.667804. Review.

PMID:
22404224
15.

Possible role for protein kinase C in the pathogenesis of inborn errors of metabolism.

Boneh A.

J Cell Biochem. 1995 Sep;59(1):27-32. Review.

PMID:
8530533
16.

Regulation of exocytosis by protein kinase C.

Morgan A, Burgoyne RD, Barclay JW, Craig TJ, Prescott GR, Ciufo LF, Evans GJ, Graham ME.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1341-4. Review.

PMID:
16246114
17.

The taurine transporter: mechanisms of regulation.

Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW.

Acta Physiol (Oxf). 2006 May-Jun;187(1-2):61-73. Review.

PMID:
16734743
18.

PKC at a glance.

Parker PJ, Murray-Rust J.

J Cell Sci. 2004 Jan 15;117(Pt 2):131-2. Review. No abstract available.

19.

Activation and regulation of protein kinase C enzymes.

Nelsestuen GL, Bazzi MD.

J Bioenerg Biomembr. 1991 Feb;23(1):43-61. Review.

PMID:
2010434
20.

Diacylglycerols as activators of protein kinase C.

Gómez-Fernández JC, Torrecillas A, Corbalán-García S.

Mol Membr Biol. 2004 Nov-Dec;21(6):339-49. Review.

PMID:
15764364

Supplemental Content

Support Center